GS/GN-code 30021098 is buiten het toepassingsgebied voor EUDR-voorbereiding.
Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins) De geïndexeerde scope-engine geeft Out of scope terug voor deze code. No Annex I scope match was found for this indexed CN code.
Waarom deze referentiepagina dat antwoord geeft.
- Codeomschrijving
- Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
- Grondslag in bijlage I
- Geen directe vermelding in bijlage I
- Brongrondslag
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Bovenliggende, onderliggende en nabijgelegen rijen.
De bibliotheekweergave dient voor referentienavigatie. Gebruik de checker wanneer u een andere code als actie wilt uitvoeren.
30farmaceutische productenout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021010antisera(2012-2016);antisera(2002-2011);antisera(1988-2001)out30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Wat dit betekent voor de voorbereiding.
Deze rij is in het huidige scoperesultaat geen directe trigger voor bewijsverzameling.
Regulation (EU) 2023/1115 Annex I — relevant productsopgehaald op 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115opgehaald op 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)opgehaald op 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)opgehaald op 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8opgehaald op 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingopgehaald op 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersopgehaald op 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)opgehaald op 2026-08-08